cytoreductive

cytoreductive

美 　英

• 網絡細胞減積術；細胞減量

例句

The long time survival rate of patients may be improved by active cytoreductive surgery followed by chemotherapy of plain-based regimen.

采用腫瘤細胞減滅術和以鉑類為主方案的化療可顯著改善預后，提高患者的生存期。

It is managed by cytoreductive surgery involving hyperthermic intraoperative intraperitoneal chemotherapy.

它由腫瘤細胞減滅術涉及溫熱腹腔化療。

A. Cytoreductive surgery improves response to chemotherapy and survival of women with advanced ovarian cancer.

外科細胞減數治療可以提高進展期卵巢癌婦女的化療效果和存活率。

The article focused on the points of pelvic anatomy and surgical skills associated with the cytoreductive surgery.

該文對腫瘤細胞減滅術相關的盆腔局部解剖和手術技巧進行了分析論述。

The other is based on the application of NIS as a novel cytoreductive gene therapy strategy.

另一種是采用NIS的新型細胞減少性的基因治療戰略。

The cytoreductive surgery was performed 1 week after last cryosurgery.

末次冷凍后1周剖腹行腫瘤細胞減滅術。

Results The 154 patients all received cytoreductive surgery and 104 of them achieved optimal cytoreduction.

結果154例患者均接受手術治療，其中104例達到理想的腫瘤細胞減滅術。

Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from digestive -tract cancer

減瘤術聯合術中腹腔內溫熱化療治療消化道腫瘤腹膜轉移

Comparison of Therapeutic Efficacy between TP Regimen and CBP Regimen on Epithelial Ovarian Cancer after Optimal Cytoreductive Operation

上皮性卵巢癌滿意減滅術后TP、CBP方案化療的療效比較

A Clinical Study of Maximum Cytoreductive Surgery for Advanced Ovarian Cancer

晚期卵巢癌理想腫瘤細胞減滅術的可行性研究

Clinical significance of secondary cytoreductive surgery for recurrent advanced ovarian cancer

復發性卵巢上皮癌二次細胞減滅術的臨床意義

The Technological Improvements of Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer

晚期卵巢癌減瘤手術技術的改進

Progression of secondary cytoreductive surgery for recurrent epithelial ovarian cancer

復發性卵巢上皮癌二次腫瘤細胞減滅術研究進展

The Rationality of Secondary Cytoreductive Surgery for Ovarian Cancer and Patients Selection

卵巢癌二次減瘤術的合理性及病例選擇

The Clinical Value of Cytoreductive Surgery for Advanced and Relapsed Endometrial Carcinoma

晚期及復發子宮內膜癌減瘤術的臨床價值

The Value of Second Cytoreductive Surgery for Recurrent Epithelial Ovarian Cancer

復發卵巢上皮癌再次腫瘤細胞減滅術的價值